Reaction
Coccidioidomycosis reporting signals
As of the last recalculation, Coccidioidomycosis appears in 1,179 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 37.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 26 | 37.4 | 37.5 |
| Fluconazole | 117 | 32.6 | 32.7 |
| Itraconazole | 17 | 26.1 | 26.1 |
| Posaconazole Delayed-Release | 15 | 24.4 | 24.4 |
| Basiliximab | 14 | 21.3 | 21.3 |
| Voriconazole Injection | 24 | 19.9 | 19.9 |
| Abacavir Sulfate | 10 | 18.3 | 18.3 |
| Posaconazole | 16 | 17.6 | 17.6 |
| Voriconazole | 29 | 17.3 | 17.3 |
| Darunavir | 12 | 14.1 | 14.2 |
| Tacrolimus Ointment 0.1% | 81 | 12.3 | 12.3 |
| Tacrolimus Extended-Release Capsules | 81 | 12.2 | 12.2 |
| Mycophenilic Acid | 13 | 11.2 | 11.2 |
| Lamivudine Oral | 15 | 10.6 | 10.6 |
| Remdesivir | 7 | 9.3 | 9.3 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 8.2 | 8.2 |
| Oseltamivir | 3 | 6.7 | 6.7 |
| Guselkumab | 9 | 4.5 | 4.5 |
| Apremilast | 19 | 2.3 | 2.3 |